臨床試驗

C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.

NCT：NCT03311451 · ACTIVE_NOT_RECRUITING

NCT IDNCT03311451

狀態ACTIVE_NOT_RECRUITING

開始日期2023-01-16

完成時間2026-12-18

SponsorMerit Medical Systems, Inc. (INDUSTRY)

First posted2017-10-17

Last updated2026-05-22

簡要摘要

The primary objective is to determine the safety and efficacy of the C2 CryoBalloon 180 Ablation System ("CryoBalloon 180") used at decreasing doses in ablation naïve patients with low- or high-grade dysplastic Barrett's Esophagus (BE) or with residual BE after resection of dysplasia or early adenocarcinoma.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。